Literature DB >> 17588960

Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.

Katarzyna A Piróg-Garcia1, Roger S Meadows, Lynette Knowles, Dick Heinegård, David J Thornton, Karl E Kadler, Raymond P Boot-Handford, Michael D Briggs.   

Abstract

Pseudoachondroplasia (PSACH) is one of the more common skeletal dysplasias and results from mutations in cartilage oligomeric matrix protein (COMP). Most COMP mutations identified to date cluster in the TSP3 repeat region of COMP and the mutant protein is retained in the rough endoplasmic reticulum (rER) of chondrocytes and may result in increased cell death. In contrast, the pathomolecular mechanism of PSACH resulting from C-terminal domain COMP mutations remain largely unknown. This study describes the generation and analysis of a murine model of mild PSACH resulting from a p.Thr583Met mutation in the C-terminal globular domain (CTD) of COMP. Mutant animals are normal at birth, but grow slower than their wild-type littermates and by 9 weeks of age they have mild short-limb dwarfism. Furthermore, by 16 months of age mutant animals exhibit severe degeneration of articular cartilage, which is consistent with early onset osteoarthritis seen in PSACH patients. In the growth plates of mutant mice the chondrocyte columns are sparser and poorly organized. Mutant COMP is secreted into the extracellular matrix, but its localization is disrupted along with the distribution of several COMP-binding proteins. Although mutant COMP is not retained within the rER there is an unfolded protein/cell stress response and chondrocyte proliferation is significantly reduced, while apoptosis is both increased and spatially dysregulated. Overall, these data suggests a mutation in the CTD of COMP exerts a dominant-negative effect on both intra- and extracellular processes. This ultimately affects the morphology and proliferation of growth plate chondrocytes, eventually leading to chondrodysplasia and reduced long bone growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588960      PMCID: PMC2674228          DOI: 10.1093/hmg/ddm155

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

1.  Thrombospondins.

Authors:  P Bornstein; E H Sage
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

2.  Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development.

Authors:  Z Shen; D Heinegård; Y Sommarin
Journal:  Matrix Biol       Date:  1995-12       Impact factor: 11.583

3.  Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion.

Authors:  Markus Schmitz; Alexander Becker; Alexander Schmitz; Christian Weirich; Mats Paulsson; Frank Zaucke; Robert Dinser
Journal:  J Biol Chem       Date:  2006-08-23       Impact factor: 5.157

4.  Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding.

Authors:  P E DiCesare; M Mörgelin; K Mann; M Paulsson
Journal:  Eur J Biochem       Date:  1994-08-01

5.  A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals.

Authors:  C A Kimmel; C Trammell
Journal:  Stain Technol       Date:  1981-09

6.  COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins.

Authors:  A Oldberg; P Antonsson; K Lindblom; D Heinegård
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

7.  Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene.

Authors:  M D Briggs; S M Hoffman; L M King; A S Olsen; H Mohrenweiser; J G Leroy; G R Mortier; D L Rimoin; R S Lachman; E S Gaines
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

8.  Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia.

Authors:  J T Hecht; L D Nelson; E Crowder; Y Wang; F F Elder; W R Harrison; C A Francomano; C K Prange; G G Lennon; M Deere
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

9.  A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix.

Authors:  D L Rimoin; I M Rasmussen; M D Briggs; P J Roughley; H E Gruber; M L Warman; B R Olsen; Y E Hsia; J Yuen; K Reinker
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

10.  Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development.

Authors:  M Amling; L Neff; S Tanaka; D Inoue; K Kuida; E Weir; W M Philbrick; A E Broadus; R Baron
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

View more
  50 in total

Review 1.  Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.

Authors:  John F Bateman; Raymond P Boot-Handford; Shireen R Lamandé
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

Review 2.  Gene cloning to clinical trials-the trials and tribulations of a life with collagen.

Authors:  Raymond P Boot-Handford
Journal:  Int J Exp Pathol       Date:  2019-03-26       Impact factor: 1.925

Review 3.  Defining the extracellular matrix using proteomics.

Authors:  Adam Byron; Jonathan D Humphries; Martin J Humphries
Journal:  Int J Exp Pathol       Date:  2013-02-19       Impact factor: 1.925

4.  Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.

Authors:  Joseph L Alcorn; Thomas M Merritt; Mary C Farach-Carson; Huiqui H Wang; Jacqueline T Hecht
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

5.  Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.

Authors:  Patrick Smits; Andrew D Bolton; Vincent Funari; Minh Hong; Eric D Boyden; Lei Lu; Danielle K Manning; Noelle D Dwyer; Jennifer L Moran; Mary Prysak; Barry Merriman; Stanley F Nelson; Luisa Bonafé; Andrea Superti-Furga; Shiro Ikegawa; Deborah Krakow; Daniel H Cohn; Tom Kirchhausen; Matthew L Warman; David R Beier
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

6.  Comparative proteomic analysis of normal and collagen IX null mouse cartilage reveals altered extracellular matrix composition and novel components of the collagen IX interactome.

Authors:  Bent Brachvogel; Frank Zaucke; Keyur Dave; Emma L Norris; Jacek Stermann; Münire Dayakli; Manuel Koch; Jeffrey J Gorman; John F Bateman; Richard Wilson
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

7.  The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.

Authors:  Kemin Tan; Mark Duquette; Andrzej Joachimiak; Jack Lawler
Journal:  FASEB J       Date:  2009-03-10       Impact factor: 5.191

Review 8.  Cartilage homeostasis in health and rheumatic diseases.

Authors:  Mary B Goldring; Kenneth B Marcu
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 9.  The unfolded protein response and its relevance to connective tissue diseases.

Authors:  Raymond P Boot-Handford; Michael D Briggs
Journal:  Cell Tissue Res       Date:  2009-10-23       Impact factor: 5.249

10.  Targeted induction of endoplasmic reticulum stress induces cartilage pathology.

Authors:  M Helen Rajpar; Ben McDermott; Louise Kung; Rachel Eardley; Lynette Knowles; Mel Heeran; David J Thornton; Richard Wilson; John F Bateman; Richard Poulsom; Peter Arvan; Karl E Kadler; Michael D Briggs; Raymond P Boot-Handford
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.